Ferric Oxide, Saccharated
(MSBRDSHNKSLACK-SWKHMZSWSA-N)
Structure
- SMILES
- OC[C@H]1O[C@@]([C@H]([C@@H]1O)O)(CO)O[C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O.[O-2].[O-2].[O-2].[Fe+3].[Fe+3]
- Molecular Formula:
- C12H22Fe2O14
- Molecular Weight:
- 501.985
- Log P:
- -5.7570
- Hydrogen Bond Acceptor:
- 11
- Hydrogen Bond Donor:
- 8
- TPSA:
- 189.53
- CAS Number(s):
- N/A
Synonym(s)
1.
Ferric Oxide, Saccharated
2.
Ferri-Saccharate
3.
Ferric Saccharate
4.
Hippiron
5.
Iron Oxide (Saccharated)
6.
Iron Sucrose
7.
Iron(III)-Hydroxide Sucrose Complex
8.
Iron-Saccharate
9.
Venofer
10.
Ferri Saccharate
11.
Iron Saccharate
12.
Saccharated Ferric Oxide
External Link(s)
| MeSH | D000077605 |
| PubChem Compound | 6850789 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Nausea | FAERS: 92 | US FAERS | |
| 2 | Extravasation | FAERS: 90 | US FAERS | |
| 3 | Hypotension | FAERS: 74 | US FAERS | |
| 4 | Dizziness | FAERS: 60 | US FAERS | |
| 5 | Pruritus | FAERS: 56 | US FAERS | |
| 6 | Vomiting | FAERS: 54 | US FAERS | |
| 7 | Urticaria | FAERS: 53 | US FAERS | |
| 8 | Back Pain | FAERS: 47 | US FAERS | |
| 9 | Burning sensation | FAERS: 41 | US FAERS | |
| 10 | Malaise | FAERS: 41 | US FAERS | |
| 11 | Arthralgia | FAERS: 38 | US FAERS | |
| 12 | Chest Pain | FAERS: 38 | US FAERS | |
| 13 | Headache | FAERS: 37 | US FAERS | |
| 14 | Hypersensitivity | FAERS: 35 | US FAERS | |
| 15 | Chills | FAERS: 33 | US FAERS | |
| 16 | Peripheral swelling | FAERS: 33 | US FAERS | |
| 17 | Chest discomfort | FAERS: 32 | US FAERS | |
| 18 | Syncope | FAERS: 32 | US FAERS | |
| 19 | Abdominal Pain | FAERS: 31 | US FAERS | |
| 20 | Infusion site pain | FAERS: 30 | US FAERS | |
| 21 | Anaphylactoid Reaction | FAERS: 29 | US FAERS | |
| 22 | Pain | FAERS: 28 | US FAERS | |
| 23 | Injection site pain | FAERS: 26 | US FAERS | |
| 24 | Erythema | FAERS: 25 | US FAERS | |
| 25 | Infusion Site Extravasation | FAERS: 25 | US FAERS | |
| 26 | Phlebitis | FAERS: 24 | US FAERS | |
| 27 | Tachycardia | FAERS: 23 | US FAERS | |
| 28 | Joint swelling | FAERS: 21 | US FAERS | |
| 29 | Flushing | FAERS: 18 | US FAERS | |
| 30 | Chromaturia | FAERS: 16 | US FAERS | |
| 31 | Pallor | FAERS: 16 | US FAERS | |
| 32 | Swelling | FAERS: 16 | US FAERS | |
| 33 | Unresponsive to stimuli | FAERS: 15 | US FAERS | |
| 34 | Fatigue | FAERS: 14 | US FAERS | |
| 35 | Overdose | FAERS: 14 | US FAERS | |
| 36 | Cyanosis | FAERS: 13 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 37 | Myalgia | FAERS: 13 | US FAERS | |
| 38 | Asthenia | FAERS: 12 | US FAERS | |
| 39 | Feeling abnormal | FAERS: 12 | US FAERS | |
| 40 | Incorrect drug administration rate | FAERS: 12 | US FAERS | |
| 41 | Infusion site swelling | FAERS: 12 | US FAERS | |
| 42 | Joint stiffness | FAERS: 12 | US FAERS | |
| 43 | Maternal exposure during pregnancy | FAERS: 12 | US FAERS | |
| 44 | Tremor | FAERS: 12 | US FAERS | |
| 45 | Abdominal discomfort | FAERS: 11 | US FAERS | |
| 46 | Bradycardia | FAERS: 11 | US FAERS | |
| 47 | Anxiety | FAERS: 10 | US FAERS | |
| 48 | Drug exposure during pregnancy | FAERS: 10 | US FAERS | |
| 49 | Feeling Cold | FAERS: 10 | US FAERS | |
| 50 | Musculoskeletal stiffness | FAERS: 10 | US FAERS | |
| 51 | Presyncope | FAERS: 9 | US FAERS | |
| 52 | Dysgeusia | FAERS: 8 | US FAERS | |
| 53 | Palpitations | FAERS: 8 | US FAERS | |
| 54 | Thrombophlebitis | FAERS: 8 | US FAERS | |
| 55 | Venous Thrombosis | FAERS: 8 | US FAERS | |
| 56 | Wrong technique in drug usage process | FAERS: 8 | US FAERS | |
| 57 | Cellulitis | FAERS: 7 | US FAERS | |
| 58 | Cold sweat | FAERS: 7 | US FAERS | |
| 59 | Infusion site erythema | FAERS: 7 | US FAERS | |
| 60 | Medication Error | FAERS: 7 | US FAERS | |
| 61 | Pulmonary Embolism | FAERS: 7 | US FAERS | |
| 62 | Acute Coronary Syndrome | FAERS: 6 | US FAERS | |
| 63 | Infusion site phlebitis | FAERS: 6 | US FAERS | |
| 64 | Injection Site Reaction | FAERS: 6 | US FAERS | |
| 65 | Injection site extravasation | FAERS: 6 | US FAERS | |
| 66 | Metabolic acidosis | FAERS: 6 | US FAERS | |
| 67 | Product quality issue | FAERS: 6 | US FAERS | |
| 68 | Respiratory distress | FAERS: 6 | US FAERS | |
| 69 | Throat irritation | FAERS: 6 | US FAERS | |
| 70 | Thrombosis | FAERS: 6 | US FAERS | |
| 71 | Anaphylactic shock | FAERS: 5 | US FAERS | |
| 72 | Angioedema | FAERS: 5 | US FAERS | |
| 73 | Cardiac Arrest | FAERS: 5 | US FAERS | |
| 74 | Cerebrovascular accident | FAERS: 5 | US FAERS | |
| 75 | Drug ineffective | FAERS: 5 | US FAERS | |
| 76 | Hypoxia | FAERS: 5 | US FAERS | |
| 77 | Incorrect dose administered | FAERS: 5 | US FAERS | |
| 78 | Incorrect route of drug administration | FAERS: 5 | US FAERS | |
| 79 | Injection site inflammation | FAERS: 5 | US FAERS | |
| 80 | Injection site phlebitis | FAERS: 5 | US FAERS | |
| 81 | Lethargy | FAERS: 5 | US FAERS | |
| 82 | Myocardial Infarction | FAERS: 5 | US FAERS | |
| 83 | No adverse event | FAERS: 5 | US FAERS | |
| 84 | Thrombocytopenia | FAERS: 5 | US FAERS | |
| 85 | Urinary tract infection | FAERS: 5 | US FAERS | |
| 86 | Accidental overdose | FAERS: 4 | US FAERS | |
| 87 | Blood iron increased | FAERS: 4 | US FAERS | |
| 88 | Disorientation | FAERS: 4 | US FAERS | |
| 89 | Drug administration error | FAERS: 4 | US FAERS | |
| 90 | Dyspepsia | FAERS: 4 | US FAERS | |
| 91 | Inappropriate schedule of drug administration | FAERS: 4 | US FAERS | |
| 92 | Infusion site thrombosis | FAERS: 4 | US FAERS | |
| 93 | Injection site thrombosis | FAERS: 4 | US FAERS | |
| 94 | Neck Pain | FAERS: 4 | US FAERS | |
| 95 | Oropharyngeal pain | FAERS: 4 | US FAERS | |
| 96 | Product preparation error | FAERS: 4 | US FAERS | |
| 97 | Retching | FAERS: 4 | US FAERS | |
| 98 | Sinus Tachycardia | FAERS: 4 | US FAERS | |
| 99 | Somnolence | FAERS: 4 | US FAERS | |
| 100 | Wheezing | FAERS: 4 | US FAERS | |
| 101 | Adverse event | FAERS: 3 | US FAERS | |
| 102 | Alopecia | FAERS: 3 | US FAERS | |
| 103 | Aspartate Aminotransferase Increased | FAERS: 3 | US FAERS | |
| 104 | Bone pain | FAERS: 3 | US FAERS | |
| 105 | Cardiac Flutter | FAERS: 3 | US FAERS | |
| 106 | Dehydration | FAERS: 3 | US FAERS | |
| 107 | Ecchymosis | FAERS: 3 | US FAERS | |
| 108 | Flank Pain | FAERS: 3 | US FAERS | |
| 109 | Infusion site inflammation | FAERS: 3 | US FAERS | |
| 110 | Infusion site necrosis | FAERS: 3 | US FAERS | |
| 111 | Injection site erythema | FAERS: 3 | US FAERS | |
| 112 | Leukocytosis | FAERS: 3 | US FAERS | |
| 113 | Menorrhagia | FAERS: 3 | US FAERS | |
| 114 | Muscle tightness | FAERS: 3 | US FAERS | |
| 115 | No reaction on previous exposure to drug | FAERS: 3 | US FAERS | |
| 116 | Pancytopenia | FAERS: 3 | US FAERS | |
| 117 | Rash erythematous | FAERS: 3 | US FAERS | |
| 118 | Respiratory Failure | FAERS: 3 | US FAERS | |
| 119 | Shock | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 120 | Supraventricular tachycardia | FAERS: 3 | US FAERS | |
| 121 | Unevaluable event | FAERS: 3 | US FAERS | |
| 122 | Vertigo | FAERS: 3 | US FAERS | |
| 123 | Wrong technique in product usage process | FAERS: 3 | US FAERS | |
| 124 | Abasia | FAERS: 2 | US FAERS | |
| 125 | Administration site reaction | FAERS: 2 | US FAERS | |
| 126 | Apparent death | FAERS: 2 | US FAERS | |
| 127 | Arthritis | FAERS: 2 | US FAERS | |
| 128 | Arthropathy | FAERS: 2 | US FAERS | |
| 129 | Asthma | FAERS: 2 | US FAERS | |
| 130 | Blood alkaline phosphatase increased | FAERS: 2 | US FAERS | |
| 131 | Blood pressure immeasurable | FAERS: 2 | US FAERS | |
| 132 | Bronchospasm | FAERS: 2 | US FAERS | |
| 133 | Constipation | FAERS: 2 | US FAERS | |
| 134 | Depressed Level of Consciousness | FAERS: 2 | US FAERS | |
| 135 | Dysphonia | FAERS: 2 | US FAERS | |
| 136 | Dysuria | FAERS: 2 | US FAERS | |
| 137 | Enterococcal infection | FAERS: 2 | US FAERS | |
| 138 | Flatulence | FAERS: 2 | US FAERS | |
| 139 | Formication | FAERS: 2 | US FAERS | |
| 140 | Gait inability | FAERS: 2 | US FAERS | |
| 141 | General physical health deterioration | FAERS: 2 | US FAERS | |
| 142 | Hemiplegia | FAERS: 2 | US FAERS | |
| 143 | Hyperventilation | FAERS: 2 | US FAERS | |
| 144 | Hypoperfusion | FAERS: 2 | US FAERS | |
| 145 | Incorrect drug administration duration | FAERS: 2 | US FAERS | |
| 146 | Infusion site pruritus | FAERS: 2 | US FAERS | |
| 147 | Infusion site reaction | FAERS: 2 | US FAERS | |
| 148 | Injection site bruising | FAERS: 2 | US FAERS | |
| 149 | Injection site mass | FAERS: 2 | US FAERS | |
| 150 | Injection site streaking | FAERS: 2 | US FAERS | |
| 151 | Intestinal infarction | FAERS: 2 | US FAERS | |
| 152 | Iron Overload | FAERS: 2 | US FAERS | |
| 153 | Joint Range of Motion Decreased | FAERS: 2 | US FAERS | |
| 154 | Laceration | FAERS: 2 | US FAERS | |
| 155 | Limb discomfort | FAERS: 2 | US FAERS | |
| 156 | Lymphangitis | FAERS: 2 | US FAERS | |
| 157 | Memory impairment | FAERS: 2 | US FAERS | |
| 158 | Mixed liver injury | FAERS: 2 | US FAERS | |
| 159 | Monoplegia | FAERS: 2 | US FAERS | |
| 160 | Muscle Rigidity | FAERS: 2 | US FAERS | |
| 161 | Musculoskeletal chest pain | FAERS: 2 | US FAERS | |
| 162 | Nervousness | FAERS: 2 | US FAERS | |
| 163 | Pericardial effusion | FAERS: 2 | US FAERS | |
| 164 | Perineal pain | FAERS: 2 | US FAERS | |
| 165 | Peripheral artery thrombosis | FAERS: 2 | US FAERS | |
| 166 | Peritonitis | FAERS: 2 | US FAERS | |
| 167 | Pneumonia | FAERS: 2 | US FAERS | |
| 168 | Polyuria | FAERS: 2 | US FAERS | |
| 169 | Procedural complication | FAERS: 2 | US FAERS | |
| 170 | Product use in unapproved indication | FAERS: 2 | US FAERS | |
| 171 | Puncture site reaction | FAERS: 2 | US FAERS | |
| 172 | Respiratory arrest | FAERS: 2 | US FAERS | |
| 173 | Septic Shock | FAERS: 2 | US FAERS | |
| 174 | Skin reaction | FAERS: 2 | US FAERS | |
| 175 | Thirst | FAERS: 2 | US FAERS | |
| 176 | Tinnitus | FAERS: 2 | US FAERS | |
| 177 | Toxicity to various agents | FAERS: 2 | US FAERS | |
| 178 | Venous thrombosis limb | FAERS: 2 | US FAERS | |
| 179 | Ventricular hypertrophy | FAERS: 2 | US FAERS | |
| 180 | Wrong drug administered | FAERS: 2 | US FAERS | |
| 181 | nervous system disorder | FAERS: 2 | US FAERS | |
| 182 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 183 | Acidosis | FAERS: 1 | US FAERS | |
| 184 | Acute myocardial infarction | FAERS: 1 | US FAERS | |
| 185 | Ageusia | FAERS: 1 | US FAERS | |
| 186 | Agitation | FAERS: 1 | US FAERS | |
| 187 | Altered state of consciousness | FAERS: 1 | US FAERS | |
| 188 | Amnesia | FAERS: 1 | US FAERS | |
| 189 | Anal abscess | FAERS: 1 | US FAERS | |
| 190 | Anal sphincter atony | FAERS: 1 | US FAERS | |
| 191 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 192 | Antibiotic resistant Staphylococcus test positive | FAERS: 1 | US FAERS | |
| 193 | Anuria | FAERS: 1 | US FAERS | |
| 194 | Aphasia | FAERS: 1 | US FAERS | |
| 195 | Ascites | FAERS: 1 | US FAERS | |
| 196 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 197 | Atrioventricular Septal Defect | FAERS: 1 | US FAERS | |
| 198 | Bladder pain | FAERS: 1 | US FAERS | |
| 199 | Bladder sphincter atony | FAERS: 1 | US FAERS | |
| 200 | Blindness | FAERS: 1 | US FAERS | |
| 201 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 202 | Blood potassium decreased | FAERS: 1 | US FAERS | |
| 203 | Blood prolactin increased | FAERS: 1 | US FAERS | |
| 204 | Blood urine present | FAERS: 1 | US FAERS | |
| 205 | Catheter site discharge | FAERS: 1 | US FAERS | |
| 206 | Catheter site infection | FAERS: 1 | US FAERS | |
| 207 | Catheter site pain | FAERS: 1 | US FAERS | |
| 208 | Catheter site swelling | FAERS: 1 | US FAERS | |
| 209 | Chemical injury | FAERS: 1 | US FAERS | |
| 210 | Chemotherapy | FAERS: 1 | US FAERS | |
| 211 | Cholecystitis | FAERS: 1 | US FAERS | |
| 212 | Contraindicated product administered | FAERS: 1 | US FAERS | |
| 213 | Crying | FAERS: 1 | US FAERS | |
| 214 | Cystitis | FAERS: 1 | US FAERS | |
| 215 | Deep Vein Thrombosis | FAERS: 1 | US FAERS | |
| 216 | Device dislocation | FAERS: 1 | US FAERS | |
| 217 | Device related infection | FAERS: 1 | US FAERS | |
| 218 | Discomfort | FAERS: 1 | US FAERS | |
| 219 | Disease recurrence | FAERS: 1 | US FAERS | |
| 220 | Drug abuse | FAERS: 1 | US FAERS | |
| 221 | Drug administered at inappropriate site | FAERS: 1 | US FAERS | |
| 222 | Drug monitoring procedure not performed | FAERS: 1 | US FAERS | |
| 223 | Drug prescribing error | FAERS: 1 | US FAERS | |
| 224 | Dry skin | FAERS: 1 | US FAERS | |
| 225 | Ear discomfort | FAERS: 1 | US FAERS | |
| 226 | Eczema | FAERS: 1 | US FAERS | |
| 227 | Electrocardiogram change | FAERS: 1 | US FAERS | |
| 228 | Emotional distress | FAERS: 1 | US FAERS | |
| 229 | Eosinophilic Fasciitis | FAERS: 1 | US FAERS | |
| 230 | Epilepsy | FAERS: 1 | US FAERS | |
| 231 | Epistaxis | FAERS: 1 | US FAERS | |
| 232 | Erythema Multiforme | FAERS: 1 | US FAERS | |
| 233 | Expired product administered | FAERS: 1 | US FAERS | |
| 234 | Eye Burns | FAERS: 1 | US FAERS | |
| 235 | Eye irritation | FAERS: 1 | US FAERS | |
| 236 | Facial Paresis | FAERS: 1 | US FAERS | |
| 237 | Fibromyalgia | FAERS: 1 | US FAERS | |
| 238 | Foaming at mouth | FAERS: 1 | US FAERS | |
| 239 | Fungal peritonitis | FAERS: 1 | US FAERS | |
| 240 | Gliosis | FAERS: 1 | US FAERS | |
| 241 | Gout | FAERS: 1 | US FAERS | |
| 242 | Hemiparesis | FAERS: 1 | US FAERS | |
| 243 | Hepatic siderosis | FAERS: 1 | US FAERS | |
| 244 | Hepatitis | FAERS: 1 | US FAERS | |
| 245 | Hypersomnia | FAERS: 1 | US FAERS | |
| 246 | Hypertensive crisis | FAERS: 1 | US FAERS | |
| 247 | Hypocapnia | FAERS: 1 | US FAERS | |
| 248 | Hypokinesia | FAERS: 1 | US FAERS | |
| 249 | Hypophagia | FAERS: 1 | US FAERS | |
| 250 | Hypothalamo-pituitary disorder | FAERS: 1 | US FAERS | |
| 251 | Hypotonic-hyporesponsive episode | FAERS: 1 | US FAERS | |
| 252 | Ileus | FAERS: 1 | US FAERS | |
| 253 | Incontinence | FAERS: 1 | US FAERS | |
| 254 | Incorrect drug dosage form administered | FAERS: 1 | US FAERS | |
| 255 | Induration | FAERS: 1 | US FAERS | |
| 256 | Infection | FAERS: 1 | US FAERS | |
| 257 | Infusion site abscess | FAERS: 1 | US FAERS | |
| 258 | Infusion site bruising | FAERS: 1 | US FAERS | |
| 259 | Infusion site cellulitis | FAERS: 1 | US FAERS | |
| 260 | Infusion site discomfort | FAERS: 1 | US FAERS | |
| 261 | Infusion site eczema | FAERS: 1 | US FAERS | |
| 262 | Infusion site induration | FAERS: 1 | US FAERS | |
| 263 | Infusion site infection | FAERS: 1 | US FAERS | |
| 264 | Infusion site irritation | FAERS: 1 | US FAERS | |
| 265 | Infusion site streaking | FAERS: 1 | US FAERS | |
| 266 | Infusion site warmth | FAERS: 1 | US FAERS | |
| 267 | Injection site burning | FAERS: 1 | US FAERS | |
| 268 | Injection site discomfort | FAERS: 1 | US FAERS | |
| 269 | Injection site irritation | FAERS: 1 | US FAERS | |
| 270 | Injection site urticaria | FAERS: 1 | US FAERS | |
| 271 | Iron deficiency | FAERS: 1 | US FAERS | |
| 272 | Klebsiella test positive | FAERS: 1 | US FAERS | |
| 273 | Kounis Syndrome | FAERS: 1 | US FAERS | |
| 274 | Larynx irritation | FAERS: 1 | US FAERS | |
| 275 | Leukopenia | FAERS: 1 | US FAERS | |
| 276 | Limb injury | FAERS: 1 | US FAERS | |
| 277 | Lip swelling | FAERS: 1 | US FAERS | |
| 278 | Livedo Reticularis | FAERS: 1 | US FAERS | |
| 279 | Liver Abscess | FAERS: 1 | US FAERS | |
| 280 | Loss of personal independence in daily activities | FAERS: 1 | US FAERS | |
| 281 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 282 | Macular degeneration | FAERS: 1 | US FAERS | |
| 283 | Megakaryocytes decreased | FAERS: 1 | US FAERS | |
| 284 | Mental status changes | FAERS: 1 | US FAERS | |
| 285 | Moaning | FAERS: 1 | US FAERS | |
| 286 | Mouth swelling | FAERS: 1 | US FAERS | |
| 287 | Musculoskeletal Pain | FAERS: 1 | US FAERS | |
| 288 | Musculoskeletal discomfort | FAERS: 1 | US FAERS | |
| 289 | Mydriasis | FAERS: 1 | US FAERS | |
| 290 | Myoglobin blood increased | FAERS: 1 | US FAERS | |
| 291 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 292 | Nerve injury | FAERS: 1 | US FAERS | |
| 293 | Neuralgia | FAERS: 1 | US FAERS | |
| 294 | Nodule | FAERS: 1 | US FAERS | |
| 295 | Ocular discomfort | FAERS: 1 | US FAERS | |
| 296 | Oliguria | FAERS: 1 | US FAERS | |
| 297 | Oral pruritus | FAERS: 1 | US FAERS | |
| 298 | Orthostatic intolerance | FAERS: 1 | US FAERS | |
| 299 | Pain of skin | FAERS: 1 | US FAERS | |
| 300 | Parotitis | FAERS: 1 | US FAERS | |
| 301 | Pelvic Pain | FAERS: 1 | US FAERS | |
| 302 | Pericarditis | FAERS: 1 | US FAERS | |
| 303 | Peritoneal Infection | FAERS: 1 | US FAERS | |
| 304 | Poor peripheral circulation | FAERS: 1 | US FAERS | |
| 305 | Porphyria non-acute | FAERS: 1 | US FAERS | |
| 306 | Post procedural swelling | FAERS: 1 | US FAERS | |
| 307 | Pre-Eclampsia | FAERS: 1 | US FAERS | |
| 308 | Product formulation issue | FAERS: 1 | US FAERS | |
| 309 | Productive Cough | FAERS: 1 | US FAERS | |
| 310 | Pulmonary Hypertension | FAERS: 1 | US FAERS | |
| 311 | Pulmonary congestion | FAERS: 1 | US FAERS | |
| 312 | Purpura | FAERS: 1 | US FAERS | |
| 313 | Purulence | FAERS: 1 | US FAERS | |
| 314 | Purulent discharge | FAERS: 1 | US FAERS | |
| 315 | QRS axis abnormal | FAERS: 1 | US FAERS | |
| 316 | Renal pain | FAERS: 1 | US FAERS | |
| 317 | Respiratory muscle weakness | FAERS: 1 | US FAERS | |
| 318 | Restlessness | FAERS: 1 | US FAERS | |
| 319 | Right ventricle outflow tract obstruction | FAERS: 1 | US FAERS | |
| 320 | Sepsis | FAERS: 1 | US FAERS | |
| 321 | Serum sickness-like reaction | FAERS: 1 | US FAERS | |
| 322 | Sinus bradycardia | FAERS: 1 | US FAERS | |
| 323 | Sinus headache | FAERS: 1 | US FAERS | |
| 324 | Skin Induration | FAERS: 1 | US FAERS | |
| 325 | Skin Ulcer | FAERS: 1 | US FAERS | |
| 326 | Skin tightness | FAERS: 1 | US FAERS | |
| 327 | Staring | FAERS: 1 | US FAERS | |
| 328 | Stridor | FAERS: 1 | US FAERS | |
| 329 | Tenosynovitis | FAERS: 1 | US FAERS | |
| 330 | Therapy cessation | FAERS: 1 | US FAERS | |
| 331 | Tooth Loss | FAERS: 1 | US FAERS | |
| 332 | Transfusion related complication | FAERS: 1 | US FAERS | |
| 333 | Trismus | FAERS: 1 | US FAERS | |
| 334 | Unresponsive to verbal stimuli | FAERS: 1 | US FAERS | |
| 335 | Urinary Incontinence | FAERS: 1 | US FAERS | |
| 336 | Urinary Retention | FAERS: 1 | US FAERS | |
| 337 | Uterine Polyp | FAERS: 1 | US FAERS | |
| 338 | Vascular Access Complication | FAERS: 1 | US FAERS | |
| 339 | Vascular rupture | FAERS: 1 | US FAERS | |
| 340 | Vasculitis | FAERS: 1 | US FAERS | |
| 341 | Venous Injury | FAERS: 1 | US FAERS | |
| 342 | Ventricular Fibrillation | FAERS: 1 | US FAERS | |
| 343 | Vessel puncture site inflammation | FAERS: 1 | US FAERS | |
| 344 | Visual Impairment | FAERS: 1 | US FAERS | |
| 345 | Vulvovaginal burning sensation | FAERS: 1 | US FAERS | |
| 346 | Weight decreased | FAERS: 1 | US FAERS | |
| 347 | Wheelchair user | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.